Article
Examination of the effectiveness of local therapy for oligo-recurrence of EGFR-mutated NSCLC.
Thoracic cancer - 1 Mar 2023
Sonoda Dai, Kondo Yasuto, Maruyama Raito, Hayashi Shoko, Naito Masahito, Mikubo Masashi, Matsui Yoshio, Shiomi Kazu, Satoh Yukitoshi
Abstract excerpt
BACKGROUND: The effectiveness of local therapy has been reported in patients with oligo-recurrence of non-small cell lung cancer (NSCLC), a metachronous recurrence with a limited number of recurrences, which can be treated with local therapy. Conversely, remarkable progress has been made in systemic therapy for NSCLC with the advent of molecular targeted therapy. In particular, epidermal growth factor receptor...
Topics
Join the communities discussing this publication.
